Expansion, carbon-neutrality and augmented reality: just a few things we’ve addressed in 2021

Submitted by Jan Ash on Wed, 22/12/2021 - 09:06

This time last year we were reflecting on the light at the end of the tunnel, with a vaccine being rolled out that would help fight COVID-19. The global situation has certainly improved since then but, unfortunately, we aren’t quite out the other side just yet. 2021 repeatedly threw challenges our way and businesses were forced to continue to adapt and evolve in order to survive. As an online education provider we were in a very fortunate position, and we’ve successfully run hundreds of online meetings over the past 12 months.

What Does an Account Executive Do, Anyway?

Submitted by Beatrice on Mon, 20/12/2021 - 11:37

As we enter the festive season, it’s time to get wrapping, cooking, and preparing yourself for the recurrent trial of explaining to your relatives what it is that you actually do for a living. If you’ve been working in account management for a while, chances are it won’t be the first year that you’ve had to politely explain that despite what Aunt Anne tells all her friends, you’re still, without a doubt, not an accountant.  

Is Factor XI Inhibition the Holy Grail of Anticoagulant Therapy?

Submitted by Beatrice on Mon, 13/12/2021 - 14:48

The media often use terms like holy grail, silver bullet, or dawn of a new age in… for new treatments that seemingly offer a cure to a given ailment without any concomitant adverse effects. This trend is particularly noticeable in oncology, with Time magazine’s front cover from May 2001 perhaps being the most famous example. However, oncology is not the only therapy area where this is apparent.

Demonstrating real change in clinical practice

Submitted by krupa.mistry on Thu, 09/12/2021 - 14:29

Between May 2019 and March 2020, The Corpus ran an educational programme in atherosclerotic cardiovascular disease (ASCVD) in the Japan-Asia Pacific region. As with many of our online meetings, these were designed to be intimate and interactive affairs with a group of approximately 20 healthcare professionals at each one-hour meeting. Addressing an identified unmet need, the focus on the series was managing low-density lipoprotein cholesterol (LDL-C) levels in patients with ASCVD and reached more than 600 healthcare professionals (HCPs) across the region. 

Vaccination Myths — The Not-So-Good, the Painfully Bad, and the Outright Ridiculous

Submitted by admin on Wed, 08/12/2021 - 12:30

Since March 2020, public interest in healthcare has skyrocketed. Prior to the pandemic, much of the population had little to no interest in the results of immunological clinical trials, possessing limited understanding of virology, vaccines and pharmaceutical developmental processes, and any knowledge of antibodies had been long forgotten post-A-level biology. Yet overnight, the mass use and often misuse of such scientific jargon by the media became the norm, and the understanding of such convoluted subjects was no longer considered a requirement limited to health professionals only.